Advanced Medical Solutionssp. z o.o.
Business and other management consultancy activities
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2008-05-14
Share capital
50,000.00 PLN
Average employment (FTE)
2 (2025)
Registered address
Aleja Ken 20 A/72, 02-797 Warszawa, Poland
Electronic delivery address
AE:PL-70965-85293-VWDUA-32
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 52 days for 2021).
- 202531/08/2026
- 202421/08/2025
- 202327/06/2024
- 202228/06/2023
- 202105/09/2022
- 202016/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 156.57kMedianUSD 66.57kAverageUSD 1.19m
Net profit
This companyUSD 26.38kMedianUSD 1.80kAverageUSD 67.05k
Operating costs
This companyUSD 122.16kMedianUSD 50.39kAverageUSD 1.01m
Assets
This companyUSD 100.62kMedianUSD 69.61kAverageUSD 2.60m
Industry
Authorized Representatives
Magdalena Beata Wiciak-Obrębska – Attorney-in-fact (sole)
Piotr Paweł Mierzejewskiage 62 – President
Manner of representation
In the case of a multi-member management board, the company may be represented by two members of the management board jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Paweł Mierzejewskiage 62 | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $4,994.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Agencja Bezpieczeństwa Biznesu Salussp. z o.o. | $232,979.60 | abbsalus.com | ||
| Mxtechsp. z o.o. | $229,370.44 | mxtech.pl | ||
| Irito - Instytut Rozwoju i Transformacji Organizacjisp. z o.o. | $185,653.54 | irito.pl | ||
| New Solutionssp. z o.o. | $124,610.75 | new-solutions.pl | ||
| Baltic Expertsp. z o.o. | $100,588.85 | balticexpert.pl | ||
| Akademia Rozwoju Systemów Sieciowychsp. z o.o. | $90,676.22 | arss.com.pl | ||
| Finco CapitalS.A. | $89,232.63 | fincocapital.pl | ||
| Taurus Consultingsp. z o.o. | $64,290.63 | taurusconsulting.pl | ||
| DCF Groupsp. z o.o. | $53,617.22 | dcfgroup.pl | ||
| Kałużyński & Madejasp. z o.o. | $44,732.60 | kaluzynskimadeja.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-05-08 | PKD change (Removed: 25 codes) | |
| 2011-03-10 | Address change (Hektarowa 2/6, 02-989, Warszawa → Aleja Ken 20 A/72, 02-797, Warszawa) | |
| 2008-05-14 | Entered in the register |
FAQ
The main business activity of Advanced Medical Solutions focuses on business and other management consultancy activities.
The company was registered in the Polish National Court Register (KRS) on May 14, 2008.
The headquarters is located at: Aleja Ken 20 A, 02-797 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 156,574 in 2025, which is a decrease of 0.6% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 26,380, meaning the company increased its profit by 5.3%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 98,923 in 2025, representing 81% of all operating expenses.
Last updated: 2026-10-07
